Chukwuemeka Ihemelandu, MBBS, is an attending surgeon in surgical oncology at MedStar Washington Hospital Center (MWHC). In addition, he is an assistant professor of Clinical Surgery (surgical oncology) at Georgetown University Medical Center.
His public service experience includes work as the medical missions coordinator for Doctors United for Medical Missions and for Surgical Eye Expeditions International. He previously was an assistant instructor of general surgery at Wake Forest University School of Medicine. At MWHC, he serves as a preceptor for the general surgery residents and general surgery journal club.
Dr. Ihemelandu has received many honors and awards for his research, writing, and presentations. Most recently, he received the Keystone Educator Award in recognition of his excellence in resident education. Dr. Ihemelandu has published numerous articles in peer-reviewed journals, including Annals of Surgical Oncology, the Journal of the American College of Surgeons and the Journal of Surgical Research. Topics of these articles have ranged from cytoreductive surgery and survival outcomes to optimal timing of systemic therapy.
Dr. Ihemelandu is a fellow of the American College of Surgeons. His professional memberships include the Society of Surgical Oncology, the Society for Surgery of the Alimentary Tract, the American Society of Clinical Oncology and the American Association for Cancer Research. He frequently lectures on the management of gastric, colorectal and breast cancer for audiences composed of medical professionals.
His medical degree (MBBS) is from the University of Nigeria College of Medicine. He completed an internship and residency in general surgery at Howard University and a fellowship in surgical oncology at Wake Forest University School of Medicine. In addition, he completed a Dr. LaSalle D. Leffall, Jr./Susan G. Komen research fellowship in health disparities at the Howard University Cancer Center.
Dr. Ihemelandu’s research interests include
- Cancer management
- Cytoreductive surgery
- Hyperthermic perioperative chemotherapy
- Gastric, colorectal and breast cancer
- Health disparities
Synergistic Enhancement of Mytomicin C: Doxorubicin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Pseudomyxoma Peritonei
Dr. Ihemelandu is the principal investigator on this research sponsored by the National Organization for Rare Disorders.
Evaluation of Adjuvant Hyperthermic Perioperative Bidirectional Intraperitoneal Gemcitabine and Systemic Pemetrexed for the Treatment of Patients with Recurrent Diffuse Malignant Peritoneal Mesothelioma
Dr. Ihemelandu also is the principal investigator for this phase 2 trial sponsored by the Mesothelioma Applied Research Foundation.